Among bicyclic non-aromatic nitrogen heterocycles, phthalimides are an interesting class of compounds with a large range of applications. Phthalimide contains an imide functional group and may be considered as nitrogen analogues of anhydrides or as diacyl derivatives of ammonia. They are lipophilic and neutral compounds and can therefore easily cross biological membranes in vivo and showing different pharmacological activities. In the present work compounds containing phthalimide subunit have been described as a scaffold to design new prototypes drug candidates with different biological activities and are used in different diseases as, for example AIDS, tumor, diabetes, multiple myeloma, convulsion, inflammation, pain, bacterial infection among others.
:
Triazine is the six-membered heterocyclic ring containing three nitrogen which replaces carbon-hydrogen unit in the
benzene ring. Based on nitrogen position present in the ring system, it is categorized in three isomeric forms i.e.1, 2, 3-triazine
(vicinal triazine), 1, 2, 4-triazine (asymmetrical triazine or isotriazine) and 1, 3, 5-triazine (symmetrical or s-triazine or cyanidine). Triazines have weakly basic property. Its isomers have much weaker resonance energy than benzene structure, so nucleophilic substitution reactions are more preferred than electrophilic substitution reactions. Triazine isomers and their derivatives
are known to play important roles possessing various activities in medicinal and agricultural fields such as anti-cancer, antiviral,
fungicidal, insecticidal, bactericidal, herbicidal, antimalarial and antimicrobial agents.
Different barriers like a blood-brain barrier in the brain restrict the transport of potential therapeutic elements for direct entry into the brain. For delivery of a wide range of therapeutic drugs directly to the brain can be achieved by direct targeting the brain via an olfactory and trigeminal neural pathway which bypasses the blood-brain barrier hence has gained more importance and considered as an accurate route of drug targeting to brain. Intranasal route transports the drug by delivering it directly to the brain and avoiding the systemic absorption which also avoids the side effect of enhancing the efficacy of nano therapeutics. As these types of drug delivery commonly targeted drug delivery to the brain via nose are complex. Different strategies applied for overcoming these challenges has been covered. Drugs to be transported through this system are usually carried out through nano particulate system known as nanotechnology which helps in transportation of drug particles directly to the central nervous system and participates in drug release through a carrier-mediated system called nano particulate system have been extensively covered within the article. Parallel to this recent advancement in brain targeted drug delivery has been thoroughly explained and characterized. Although direct drug delivery to the brain is a vital challenge for researchers which can be overcome by using different types of strategies that have been covered under this article.
The modulation of immune system activity is a required pharmacological intervention for many medical conditions. Immunosuppression is integral to the treatment of autoimmune diseases and allergies, and the inhibition and prevention of immune responses also constitutes a prominent treatment aim for transplant recipients. Conversely, immune system stimulation is adopted for a number of infect ions and cancers. With traditional immuno modulatory drugs continuing to exhib it limited efficacy and adverse side effects, the drive to develop new, improved, and specifically targeted immunotherapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.